Replies to post #308 on Aptose Biosciences Inc (APTO)

[dcaf7]

Yes, unless they want to recruit Ven-naive patients. But if I heard it correctly, they are planing to negotiate a single-arm Tusp/Ven trial for accelerated approval. Therefore, it is absolutely critical what FDA wants to see, ORR and mDoR should be pre-determined.